ArticleAnnals of biomedical engineering2026
Strain Energy Minimization Technique to Design a Surgical Heart Valve Using a Novel Polymer.
Article in Annals of biomedical engineering, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Design and Fabrication of 3D-Printed Biomimetic Fiber-Reinforced Polymeric Aortic Valves for Improved Stress Distribution.Annals of biomedical engineering · 2026Article
- Development and preclinical results of a transcatheter aortic valve implant with novel polymeric leaflets.NPJ cardiovascular health · 2026Article
- Polymeric mitral valve replacement in rheumatic heart disease: hemodynamic and early clinical outcomes from a dedicated sub-analysis of the India Surgical Trial.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe natural aortic heart valve exhibits an exceptional balance of durability and efficiency, enabling over two billion cycles during a human lifespan. Designing a prosthetic valve that replicates these attributes presents significant challenges. The development of polymeric heart valves offers a promising alternative to existing biologic and mechanical options, aiming to improve durability and hemodynamic performance. This study focuses on the optimized design of the Foldax TRIA polymeric heart valve, leveraging computational modeling to minimize strain energy and enhance structural integrity.
methodsA fully three-dimensional computational model of the TRIA valve was developed using LS-Dyna to simulate its behavior across a full cardiac cycle and optimize for fully open and fully closed configurations. The model incorporated an explicit finite element formulation without symmetry constraints, ensuring accurate representation of valve dynamics. The leaflets, composed of LifePolymer™ (a proprietary silicone urethane-urea), and the frame, made from Solvay Zeniva® PEEK, were analyzed for strain energy distribution. A perturbation analysis was conducted by varying leaflet width to assess its impact on strain distribution, durability, and kinematic efficiency. Additionally, hydrodynamic performance was evaluated using a pulse duplicator system.
resultsThe computational analysis identified an optimal leaflet width that minimized strain energy and provided uniform stress distribution, reducing the potential for long-term material fatigue. Leaflets that deviated from this optimal width exhibited excessive strain at critical points, leading to potential durability concerns. Hydrodynamic testing demonstrated that the TRIA valve exhibited a low pressure gradient and an efficient equivalent orifice area (EOA) compared to a leading bioprosthetic control valve. Long-term durability testing indicated stable valve performance over 600 million cycles, equivalent to nearly 20 years of use.
conclusionThe optimized design of the Foldax TRIA polymeric heart valve successfully minimizes strain energy while maximizing hydrodynamic efficiency. Computational and experimental results suggest that this novel polymeric valve provides a viable, long-lasting alternative to traditional heart valve prostheses. Future studies should focus on in vivo validation to further establish clinical efficacy and longevity.
Indexed as
Identifiers
41252100What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.